These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7695815)

  • 41. [Activation of plasminogen and prothrombin by immobilized activators -- urokinase and thromboplastin (author's transl)].
    Rybák M; Coupek J
    Cas Lek Cesk; 1980 Oct; 119(40-41):1106-8. PubMed ID: 7026035
    [No Abstract]   [Full Text] [Related]  

  • 42. Urokinase-type plasminogen activator and its specific receptor in high metastatic and non-metastatic cell lines derived from human lung adenocarcinoma.
    Hagiya Y; Fukao H; Ueshima S; Inufusa H; Izaki S; Kamiishi H; Okada K; Matsuo O
    Thromb Res; 1992 Feb; 65(3):449-56. PubMed ID: 1321513
    [No Abstract]   [Full Text] [Related]  

  • 43. Plasminogen-receptor
    Flick MJ; Bugge TH
    J Thromb Haemost; 2017 Jan; 15(1):150-154. PubMed ID: 27740735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA.
    Verde P; Stoppelli MP; Galeffi P; Di Nocera P; Blasi F
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4727-31. PubMed ID: 6589620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The small-t protein of SV40 is required for loss of actin cable networks and plasminogen activator synthesis in transformed rat cells.
    Topp WC; Rifkin DB
    Virology; 1980 Oct; 106(2):282-91. PubMed ID: 6254251
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of urokinase synthesis and cell surface binding alters the motile behavior of embryonic endocardial-derived mesenchymal cells in vitro.
    McGuire PG; Alexander SM
    Development; 1993 Jul; 118(3):931-9. PubMed ID: 8076527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferon inhibits the release of plasminogen activator from SV3T3 cells.
    Schroder EW; Chou IN; Jaken S; Black PH
    Nature; 1978 Dec 21-28; 276(5690):828-9. PubMed ID: 214713
    [No Abstract]   [Full Text] [Related]  

  • 48. Assay of effects of interferon on plasminogen activator.
    Schroder EW; Black PH
    Methods Enzymol; 1981; 79(Pt B):336-42. PubMed ID: 6173681
    [No Abstract]   [Full Text] [Related]  

  • 49. Gene expression profiling: a 'fishing expedition' in search of dialysis biocompatibility.
    Pecoits-Filho R
    Blood Purif; 2006; 24(2):234-5. PubMed ID: 16428881
    [No Abstract]   [Full Text] [Related]  

  • 50. Mutations in the neoplastically transformed human cells.
    Kakunaga T
    Carcinog Compr Surv; 1985; 9():205-16. PubMed ID: 4053075
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors.
    Go Y; Chintala SK; Mohanam S; Gokaslan Z; Venkaiah B; Bjerkvig R; Oka K; Nicolson GL; Sawaya R; Rao JS
    Clin Exp Metastasis; 1997 Jul; 15(4):440-6. PubMed ID: 9219733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post-transcriptional regulation of gene expression in the plasminogen activation system.
    Montuori N; Rossi G; Ragno P
    Biol Chem; 2002 Jan; 383(1):47-53. PubMed ID: 11928821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimessenger oligonucleotide for urokinase receptor gene inhibits invasivity of transformed human fibroblasts.
    Quattrone A; Fibbi G; Anichini E; Pucci M; Zamperini A; Capaccioli S; Del Rosso M
    Anticancer Drug Des; 1995 Jan; 10(1):97-102. PubMed ID: 7695815
    [No Abstract]   [Full Text] [Related]  

  • 54. Reversion of the invasive phenotype of transformed human fibroblasts by anti-messenger oligonucleotide inhibition of urokinase receptor gene expression.
    Quattrone A; Fibbi G; Anichini E; Pucci M; Zamperini A; Capaccioli S; Del Rosso M
    Cancer Res; 1995 Jan; 55(1):90-5. PubMed ID: 7805047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Receptors for plasminogen activator, urokinase, in normal and Rous sarcoma virus-transformed mouse fibroblasts.
    Del Rosso M; Dini G; Fibbi G
    Cancer Res; 1985 Feb; 45(2):630-6. PubMed ID: 2981611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of type I collagenase expression by antisense RNA in melanoma cells results in reduced synthesis of the urokinase-type plasminogen activator receptor.
    Durko M; Brodt P
    Biochem Biophys Res Commun; 1998 Jun; 247(2):342-8. PubMed ID: 9642128
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.